The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
Chronic kidney disease (CKD) is associated with accelerated progression of cardiovascular disease, perhaps because patients with CKD have a high burden of traditional cardiovascular risk factors ...
Kidney health is essential for your overall health and one of the best ways to measure it is through your creatinine levels ...
Organ donation registration can be completed through the Ohio Bureau of Motor Vehicles. Living donors can contact one of two ...
Chronic Kidney Disease (CKD): A long-term condition where the kidneys do not work effectively, leading to a gradual decline in kidney function. Glomerular Filtration Rate (GFR): A test used to ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
At least 7 million Filipinos are suffering from chronic kidney disease (CKD ... higher or delay the deterioration of the GFR to end-stage renal disease (ESRD). What are these steps?
The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...
Transdermal GFR System (TGFR) is a first-in-kind product ... More than 800 million people have Chronic Kidney Disease (CKD), one of the world's leading causes of mortality worldwide, with ...
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.The transdermal GFR ...